Previous 10 | Next 10 |
EDEN PRAIRIE, Minn., Sept. 19, 2019 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (Nasdaq:CHFS) today announced that Claudia Napal Drayton, the company’s CFO, will be presenting and meeting with investors at the 2019 Landenburg Thalmann’s 2019 Healthcare Conference on September 24, ...
EDEN PRAIRIE, Minn., Sept. 17, 2019 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ: CHFS) announced today that it will host a conference call and webcast at 1:00 PM ET on Wednesday, September 25, 2019 to discuss the results of a multicenter, retrospective study involving pediatric patients...
Gainers: Alder BioPharmaceuticals (NASDAQ: ALDR ) +84% . SemGroup Corporation (NYSE: SEMG ) +63% . Yuma Energy (NYSEMKT: YUMA ) +63% . Wins Finance Holdings (NASDAQ: WINS ) +55% . Whiting Petroleum Corporation (NYSE: WLL ) +43% . New Concept Energy (NYSEMKT: GBR ) +34% . Califo...
EDEN PRAIRIE, Minn., Sept. 10, 2019 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (Nasdaq:CHFS) today announced it would be exhibiting at the 23 rd Annual Scientific Meeting of the Heart Failure Society of America from September 14-16, 2019. The conference is being held at the Pennsylvania Conve...
EDEN PRAIRIE, Minn., Sept. 04, 2019 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (Nasdaq:CHFS) today announced that Maria Rosa Costanzo, M.D. has been appointed to the Company's Board of Directors. Dr. Costanzo is the medical director, Heart Failure Research, at Advocate Heart Institute, and ...
EDEN PRAIRIE, Minn., Aug. 08, 2019 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (Nasdaq: CHFS) announced today the publication of a study in Circulation Heart Failure 1 highlighting the benefits of decongestion outweigh concerns from previous studies that showed a rise in creatinine le...
CHF Solutions, Inc. (CHFS) Q2 2019 Earnings Conference Call August 6, 2019 9:00 AM ET Company Participants Scott Gordon - Managing Director of CORE IR John Erb - Chairman and Chief Executive Officer Claudia Drayton - Chief Financial and Officer Nestor Jaramillo - Chief Commerci...
CHF Solutions ( CHFS ) Q2 results : Revenues: $1.7M (+54.5%). More news on: CHF Solutions, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, , Read more ...
EDEN PRAIRIE, Minn., Aug. 06, 2019 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (Nasdaq: CHFS), a medical device company focused on developing, manufacturing and commercializing a clinically proven alternative to diuretics for the treatment of fluid overload, announced today its results fo...
EDEN PRAIRIE, Minn., July 30, 2019 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ: CHFS) announces today that its second quarter 2019 financial results will be released on Tuesday, August 6, 2019. The company will host a conference call and webcast at 9:00 AM ET that morning, during which ...
News, Short Squeeze, Breakout and More Instantly...
EDEN PRAIRIE, Minn., May 17, 2021 (GLOBE NEWSWIRE) -- Data supporting the effectiveness of Aquadex FlexFlow ® system in the treatment of acutely decompensated heart failure (ADHF) patients was presented May 16 th at the 2021 American College of Cardiology conference (ACC). ...
EDEN PRAIRIE, Minn., May 13, 2021 (GLOBE NEWSWIRE) -- Reaffirming its commitment to expanding access to life-saving ultrafiltration therapies for adult and pediatric patients suffering from fluid overload, Nuwellis, Inc. (Nasdaq: NUWE), formerly CHF Solutions, Inc., today announced that its...
EDEN PRAIRIE, Minn., May 11, 2021 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) (previously CHF Solutions, Inc.) announced today its results for the first quarter ended March 31, 2021, which included the following highlights: Completed corporate rebranding from CHF Solutions, In...